Codes / ICD10CM / T65.5X

T65.5X Toxic effect of nitroglycerin and other nitric acids and esters

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Nitroglycerin and Other Nitric Acids and Esters

Summary

This condition describes adverse health effects resulting from exposure to nitroglycerin or related nitric acids and esters. These substances can cause toxicity through ingestion, inhalation, or dermal contact, leading to systemic effects primarily affecting cardiovascular and neurological systems.

Causes

The toxic effect is caused by exposure to nitroglycerin or other nitric acids and esters, which may occur through accidental or intentional ingestion, inhalation of vapors, or skin absorption. Common sources include pharmaceutical preparations, industrial chemicals, or contaminated materials.

Risk Factors

  • Accidental ingestion of nitroglycerin-containing medications (e.g., for angina).
  • Occupational exposure in industries handling nitroglycerin or related compounds.
  • Intentional overdose or misuse of nitroglycerin products.
  • Prolonged or high-dose exposure to nitric acid esters in industrial settings.

Symptoms

  • Headache, dizziness, and lightheadedness.
  • Hypotension (low blood pressure) and tachycardia (rapid heart rate).
  • Nausea, vomiting, and abdominal pain.
  • Flushing, sweating, and skin irritation.
  • In severe cases, syncope (fainting), seizures, or cardiovascular collapse.

Diagnosis

Diagnosis is based on clinical presentation, history of exposure, and exclusion of other causes. Laboratory tests may detect nitroglycerin or its metabolites, though rapid clinical assessment is critical due to potential for rapid deterioration.

Treatment Options

Treatment focuses on stabilizing vital signs, managing hypotension, and supporting respiratory function. Activated charcoal may be used if ingestion is recent. Intravenous fluids and vasopressors may be required for severe hypotension. Monitoring for cardiac and neurological complications is essential.

Prognosis and Follow-Up

Prognosis depends on the dose and duration of exposure. Mild cases often resolve with supportive care, while severe exposure may lead to prolonged hypotension or organ damage. Follow-up includes monitoring for delayed effects and assessing for underlying exposure risks.

Complications

  • Persistent hypotension requiring intensive care.
  • Cardiac arrhythmias or myocardial ischemia.
  • Neurological deficits from cerebral hypoperfusion.
  • Skin or mucosal damage from dermal or inhalation exposure.

Lifestyle & Prevention

  • Store nitroglycerin and related products securely, out of reach of children.
  • Use personal protective equipment (PPE) when handling industrial nitric acid esters.
  • Follow dosing instructions carefully for pharmaceutical nitroglycerin.
  • Avoid mixing nitroglycerin with alcohol or other vasodilators.

When to Seek Professional Help

Seek immediate medical attention if exposure is suspected, especially with symptoms like severe dizziness, fainting, or chest pain. Emergency care is critical for large ingestions or occupational exposures.

Tips for Medical Coders

Document the specific substance (nitroglycerin or other nitric acids/esters) and route of exposure (ingestion, inhalation, dermal) to support code assignment. Include details on clinical presentation and treatment to clarify the toxic effect. Ensure documentation aligns with ICD-10-CM guidelines for toxic effects.

Book a walkthrough

T65.5X policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.